
Frequently asked questions
The following questions are often asked by people contacting Retina UK.
Search results
The following questions are often asked by people contacting Retina UK.
Elena Piotter, a PhD student working in Robert MacLaren’s group in the Nuffield Laboratory of Ophthalmology at the University of Oxford, is currently researching DNA and RNA base editing tools aiming to correct pathogenic mutations in ABCA4.
Inflammation and retinal degeneration in retinitis pigmentosa: Can lessons learned in the lab help us identify treatments in the clinic?
This session will introduce the technique of optogenetics and its potential for development into a treatment for IRDs.
A general overview of the clinical trials process and practicalities, including issues to consider if you are given the opportunity to take part.
Prof Dominic Ffytche will provide an explanation of what Charles Bonnet Syndrome is, the science behind it, and share some potential coping strategies for people who experience visual hallucinations.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Martin started volunteering for Retina UK in 2014 after retiring as a Chartered Civil Engineer.
With a significant proportion of inherited retinal conditions being caused by unidentified genetic faults, and many families unable to get clear results from genetic tests in clinic, the project set out to solve previously undiagnosable cases and discover more of the genes and mutations that are associated with sight loss.
A chat with our founder, Lynda Cantor MBE and our (former) Head of Fundraising, Deborah Laing.